Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 88

1.

A risk prediction algorithm based on family history and common genetic variants: application to prostate cancer with potential clinical impact.

Macinnis RJ, Antoniou AC, Eeles RA, Severi G, Al Olama AA, McGuffog L, Kote-Jarai Z, Guy M, O'Brien LT, Hall AL, Wilkinson RA, Sawyer E, Ardern-Jones AT, Dearnaley DP, Horwich A, Khoo VS, Parker CC, Huddart RA, Van As N, McCredie MR, English DR, Giles GG, Hopper JL, Easton DF.

Genet Epidemiol. 2011 Sep;35(6):549-56. doi: 10.1002/gepi.20605. Epub 2011 Jul 18.

2.

Increased cancer risks for relatives of very early-onset breast cancer cases with and without BRCA1 and BRCA2 mutations.

Dite GS, Whittemore AS, Knight JA, John EM, Milne RL, Andrulis IL, Southey MC, McCredie MR, Giles GG, Miron A, Phipps AI, West DW, Hopper JL.

Br J Cancer. 2010 Sep 28;103(7):1103-8. doi: 10.1038/sj.bjc.6605876. Epub 2010 Sep 7.

3.

Consequences in women of participating in a study of the natural history of cervical intraepithelial neoplasia 3.

McCredie MR, Paul C, Sharples KJ, Baranyai J, Medley G, Skegg DC, Jones RW.

Aust N Z J Obstet Gynaecol. 2010 Aug;50(4):363-70. doi: 10.1111/j.1479-828X.2010.01170.x.

PMID:
20716265
4.

Population-based estimate of the contribution of TP53 mutations to subgroups of early-onset breast cancer: Australian Breast Cancer Family Study.

Mouchawar J, Korch C, Byers T, Pitts TM, Li E, McCredie MR, Giles GG, Hopper JL, Southey MC.

Cancer Res. 2010 Jun 15;70(12):4795-800. doi: 10.1158/0008-5472.CAN-09-0851. Epub 2010 May 25.

5.

Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study.

van Leeuwen MT, Webster AC, McCredie MR, Stewart JH, McDonald SP, Amin J, Kaldor JM, Chapman JR, Vajdic CM, Grulich AE.

BMJ. 2010 Feb 11;340:c570. doi: 10.1136/bmj.c570.

6.

Cutaneous melanoma is related to immune suppression in kidney transplant recipients.

Vajdic CM, van Leeuwen MT, Webster AC, McCredie MR, Stewart JH, Chapman JR, Amin J, McDonald SP, Grulich AE.

Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(8):2297-303. doi: 10.1158/1055-9965.EPI-09-0278. Epub 2009 Jul 21.

7.

The pattern of excess cancer in dialysis and transplantation.

Stewart JH, Vajdic CM, van Leeuwen MT, Amin J, Webster AC, Chapman JR, McDonald SP, Grulich AE, McCredie MR.

Nephrol Dial Transplant. 2009 Oct;24(10):3225-31. doi: 10.1093/ndt/gfp331. Epub 2009 Jul 8.

PMID:
19589786
8.

Prostate cancer segregation analyses using 4390 families from UK and Australian population-based studies.

MacInnis RJ, Antoniou AC, Eeles RA, Severi G, Guy M, McGuffog L, Hall AL, O'Brien LT, Wilkinson RA, Dearnaley DP, Ardern-Jones AT, Horwich A, Khoo VS, Parker CC, Huddart RA, McCredie MR, Smith C, Southey MC, Staples MP, English DR, Hopper JL, Giles GG, Easton DF.

Genet Epidemiol. 2010 Jan;34(1):42-50. doi: 10.1002/gepi.20433.

PMID:
19492347
9.

Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation.

van Leeuwen MT, Grulich AE, Webster AC, McCredie MR, Stewart JH, McDonald SP, Amin J, Kaldor JM, Chapman JR, Vajdic CM.

Blood. 2009 Jul 16;114(3):630-7. doi: 10.1182/blood-2009-02-202507. Epub 2009 May 14.

10.

An international case-control study of maternal diet during pregnancy and childhood brain tumor risk: a histology-specific analysis by food group.

Pogoda JM, Preston-Martin S, Howe G, Lubin F, Mueller BA, Holly EA, Filippini G, Peris-Bonet R, McCredie MR, Cordier S, Choi W.

Ann Epidemiol. 2009 Mar;19(3):148-60. doi: 10.1016/j.annepidem.2008.12.011.

11.

Immunosuppression and other risk factors for lip cancer after kidney transplantation.

van Leeuwen MT, Grulich AE, McDonald SP, McCredie MR, Amin J, Stewart JH, Webster AC, Chapman JR, Vajdic CM.

Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):561-9. doi: 10.1158/1055-9965.EPI-08-0919. Epub 2009 Feb 3.

12.

Predictors of mammographic density: insights gained from a novel regression analysis of a twin study.

Dite GS, Gurrin LC, Byrnes GB, Stone J, Gunasekara A, McCredie MR, English DR, Giles GG, Cawson J, Hegele RA, Chiarelli AM, Yaffe MJ, Boyd NF, Hopper JL.

Cancer Epidemiol Biomarkers Prev. 2008 Dec;17(12):3474-81. doi: 10.1158/1055-9965.EPI-07-2636.

13.

Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study.

McCredie MR, Sharples KJ, Paul C, Baranyai J, Medley G, Jones RW, Skegg DC.

Lancet Oncol. 2008 May;9(5):425-34. doi: 10.1016/S1470-2045(08)70103-7. Epub 2008 Apr 11.

PMID:
18407790
14.

Is MSH2 a breast cancer susceptibility gene?

Wong EM, Tesoriero AA, Pupo GM; kConFab; ABCFS, McCredie MR, Giles GG, Hopper JL, Mann GJ, Goldgar DE, Southey MC.

Fam Cancer. 2008;7(2):151-5. Epub 2007 Oct 6.

PMID:
17922223
15.

Trends in incidence of treated end-stage renal disease, overall and by primary renal disease, in persons aged 20-64 years in Europe, Canada and the Asia-Pacific region, 1998-2002.

Stewart JH, McCredie MR, Williams SM, Jager KJ, Trpeski L, McDonald SP; ESRD Incidence Study Group.

Nephrology (Carlton). 2007 Oct;12(5):520-7.

PMID:
17803478
16.

Increased incidence of squamous cell carcinoma of eye after kidney transplantation.

Vajdic CM, van Leeuwen MT, McDonald SP, McCredie MR, Law M, Chapman JR, Webster AC, Kaldor JM, Grulich AE.

J Natl Cancer Inst. 2007 Sep 5;99(17):1340-2. Epub 2007 Aug 14.

PMID:
17698951
17.

Is BRCA2 c.9079 G>A a predisposing variant for early onset breast cancer?

Hammet F, George J, Tesoriero AA, Jenkins MA, Schroen C, Smith L, Grabosch-Meehan A, Dite G, McCredie MR, Giles GG, Tavtigian SV, Hopper JL, Southey MC.

Breast Cancer Res Treat. 2008 May;109(1):177-9. Epub 2007 Jun 5. No abstract available.

PMID:
17549625
18.

Fuhrman grading is not appropriate for chromophobe renal cell carcinoma.

Delahunt B, Sika-Paotonu D, Bethwaite PB, McCredie MR, Martignoni G, Eble JN, Jordan TW.

Am J Surg Pathol. 2007 Jun;31(6):957-60.

PMID:
17527087
19.

The evolution of collagen expression in sarcomatoid renal cell carcinoma.

Delahunt B, Bethwaite PB, McCredie MR, Nacey JN.

Hum Pathol. 2007 Sep;38(9):1372-7. Epub 2007 May 22.

PMID:
17521699
20.

A systematic approach to analysing gene-gene interactions: polymorphisms at the microsomal epoxide hydrolase EPHX and glutathione S-transferase GSTM1, GSTT1, and GSTP1 loci and breast cancer risk.

Spurdle AB, Chang JH, Byrnes GB, Chen X, Dite GS, McCredie MR, Giles GG, Southey MC, Chenevix-Trench G, Hopper JL.

Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):769-74.

Supplemental Content

Loading ...
Support Center